Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan
Ageing Research Reviews · 2027-01 · 123 · 103437
DOI: 10.1016/j.arr.2026.103437 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2027-01. Verfasst von Cristhian F Montenegro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Exercise Science Research Center, Molecular Muscle Mass Regulation Laboratory, Department of Health, Human Performance, and Recreation, University of…. Die Arbeit nennt 139 Literaturangaben. Gefördert von: NIA NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Age-associated loss of muscle mass and function, termed sarcopenia, increases morbidity and mortality risks concomitant with decreased physical activity. Chronic exercise training is the most effective countermeasure against sarcopenia, but physical limitations create a barrier to participation in the elderly. Investigation into alternative pharmaceutical and nutraceutical treatments to prevent sarcopenia and maintain muscle plasticity late-in-life are therefore warranted. Polyamine metabolism regulates many facets of skeletal muscle biology with the potential for targeted treatments in conditions of compromised muscle health and plasticity. Particularly, spermidine is shown to benefit muscle health in mammalian models of ageing and exercise training. Endogenous production of spermidine is partially regulated by the enzyme spermine oxidase (SMOX). SMOX catabolism cleaves spermine into spermidine to maintain a healthy polyamine pool. Anabolic signaling regulates SMOX expression suggesting a supporting role of polyamines during muscle hypertrophy. SMOX overexpression in skeletal muscle retains muscle fiber size in atrophy-inducing animal models (e.g. immobilization, fasting, denervation) potentially driven by reciprocal downregulation of p21, a marker of cellular senescence. In satellite cells, spermidine improves satellite cell function by restoring autophagy and mitophagy, potentially related to anti-ageing Yamanaka factors. Abundance of SMOX is highest in fast-twitch muscle fiber types but can respond in a fiber-type and exercise dependent manner. In humans, higher basal SMOX expression after strength training correlates to higher strength gains, but investigations of SMOX's actions in humans are lacking. Further defining the role of SMOX in animal and human models will facilitate future skeletal muscle-specific therapeutics to promote youthfulness during ageing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Exercise Science Research Center, Molecular Muscle Mass Regulation Laboratory, Department of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, AR, USA.
- Exercise Science Research Center, Molecular Muscle Mass Regulation Laboratory, Department of Health, Human Performance, and Recreation, University of Arkansas, Fayetteville, AR, USA; NextGen Precision Health, Molecular…
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Montenegro, C. F., Murach, K. A., & Chambers, T. L. (2027). Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan. Ageing Research Reviews, 123, 103437. https://doi.org/10.1016/j.arr.2026.103437
Vancouver
Montenegro CF, Murach KA, Chambers TL. Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan. Ageing Research Reviews. 2027;123:103437. doi:10.1016/j.arr.2026.103437
BibTeX
@article{Montenegro2027,
author = {Montenegro, Cristhian F and Murach, Kevin A and Chambers, Toby L},
title = {Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan},
journal = {Ageing Research Reviews},
year = {2027},
volume = {123},
pages = {103437},
doi = {10.1016/j.arr.2026.103437}
}
EUVIMED